drugset / Trial / NCT00732680

Benefits of the Use of Botox in the Treatment of Empty Nose Syndrome Syndrome

NCT00732680

Phase 1/2 Terminated 9 enrolled Mayo Clinic
NaSingle-groupOpen-labelTreatment

Summary

Empty Nose Syndrome patients suffer from disabling physical symptoms and considerable distress. To date there is no definitive cure for these symptoms. Established treatment modalities include saline irrigation, surgical implantation of materials or simply use of cotton wads/ silicon cones to simulate the resistive action to airflow of the resected turbinates. This study will research the effectiveness of a new treatment modality in the treatment of Empty Nose Syndrome. This novel treatment method involves the use of botulinum toxin type A (Botox).

Timeline

Start
2008-12
Primary completion
2009-11
Completion
2009-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 10 iu Intramuscular

Indications